BioMedical Enterprises launched the HammerLock 2 Intramedullary Nitinol Fixation System.
This is the next generation of the HammerLock implant with Nitinol technology, which is designed to provide surgeons with an intramedullary implant that does not require freezing. It is intended as a solution for hammertoe fixation. The HammerLock 2 is designed to fit a wider range of anatomies, and it includes many points of stabilization within the toe to prevent rotation.
More articles on devices:
Alphatec Spine 3Q revenue up 2%: 10 key concepts
NuVasive's 3Q revenue up 12.3%: 10 things to know
Zimmer Biomet names new leaders